Atlas Trials

Phase 1/2 Study of IMC-R117C in Selected Advanced Cancers

Clinical trial NCT06840119 · RECRUITING

Trial details

NCT number
NCT06840119
Sponsor
Immunocore Ltd
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
CancerHLA-A*02:01-positive
Start date
2024-01-10
Primary completion
2026-11-30
Enrollment
600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.